Dr. Kumar’s Take:
This study adds clinical evidence that combining vitamin D3 and vitamin K2 improves lumbar spine bone density in postmenopausal women with osteoporosis. Each vitamin alone did better than calcium, and the two together did better than either alone. One caveat matters: the forms used were prescription drugs (alfacalcidol, an active form of vitamin D3, and high-dose menatetrenone, a form of K2), not typical over-the-counter supplements, and the trial measured bone density rather than fractures.
Key Takeaways:
✔ Vitamin D3 alone and vitamin K2 alone each produced a significant increase in lumbar spine bone density compared with calcium.
✔ The combination of vitamin D3 and K2 produced a significantly greater increase in bone density than calcium, D3 alone, or K2 alone.
✔ The calcium group showed a significant decline in bone density over the 2 years.
Actionable tip:
If you’re a postmenopausal woman with osteoporosis, this is a trial worth raising with your doctor. In it, the pairing outperformed calcium alone for spine bone density, but the doses and forms were prescription grade, so results from store-bought D3 and K2 may differ.
Brief Summary:
This was a randomized trial of 92 postmenopausal women with osteoporosis, aged 55 to 81, all more than five years past menopause, conducted at a Japanese university clinic. Participants were randomly divided into four groups: vitamin D3 (1alpha hydroxyvitamin D3, 0.75 micrograms per day), vitamin K2 (menatetrenone, 45 mg per day), vitamin D3 plus vitamin K2, or calcium (calcium lactate, 2 g per day). Bone mineral density of the lumbar spine at L2 to L4 was measured by dual energy x-ray absorptiometry at 0, 1, and 2 years after treatment started.
The results showed that:
- Calcium alone led to a significant decline in bone density
- Vitamin D3 alone and vitamin K2 alone each increased bone density relative to calcium
- Combining D3 and K2 increased bone density more than calcium, D3 alone, or K2 alone
The groups were comparable at baseline in age, body mass index, years since menopause, and starting bone density.
Study Design:
- Type: 2-year randomized clinical trial
- Participants: 92 postmenopausal women (ages 55 to 81) with osteoporosis, more than 5 years past menopause
- Groups:
- Vitamin D3, 1alpha hydroxyvitamin D3, 0.75 µg/day (n = 29)
- Vitamin K2, menatetrenone, 45 mg/day (n = 22)
- Vitamin D3 plus vitamin K2 (n = 21)
- Calcium lactate, 2 g/day (n = 20)
- Primary Outcome: Lumbar spine BMD at L2 to L4, measured by DXA at 0, 1, and 2 years
Results:
- Calcium group: a significant decrease in bone density (p < 0.001)
- Vitamin D3 group: a significant increase compared with calcium (p < 0.05)
- Vitamin K2 group: a significant increase compared with calcium (p < 0.001)
- Combination group: a significant increase compared with calcium (p < 0.0001), compared with D3 alone (p < 0.05), and compared with K2 alone (p < 0.01)
- The combination outperformed every other group in the trial.
How Vitamin D3 and K2 Support Bone Health
Vitamin D3 helps your gut absorb calcium and stimulates the production of osteocalcin, a protein that helps build bone. But osteocalcin needs to be activated to work, this is where vitamin K2 comes in. K2 activates osteocalcin through a process called carboxylation, helping the calcium bind properly to bone instead of soft tissues.
That biology is the standard explanation for the pattern seen here. This trial measured bone density, not the mechanism, so treat the explanation as background rather than something the study itself demonstrated.
Related Studies and Research
Investigates combined vitamin D3 and K2 supplementation effects on bone mineral density: Evaluates how D3 and K2 together influence BMD changes in aging adults.
Explores natto intake’s association with reduced bone loss rates in postmenopausal women: Links fermented soy consumption to lower bone turnover.
Review of MK-7 supplementation effects on bone quality, including compression and impact strength metrics: Details improvements in skeletal biomechanical properties.
Examines warfarin’s influence on bone mineral density reduction and fracture incidence: Assesses negative impacts of long-term anticoagulation.
Frequently Asked Questions
Should I take vitamin D3 and K2 together?
In this trial, the pair beat either vitamin alone for lumbar spine bone density in postmenopausal women with osteoporosis. The trial used prescription forms (alfacalcidol and 45 mg menatetrenone), so it does not directly test ordinary supplements. It is worth raising with your own physician.
What type of vitamin K2 was used?
The study used menatetrenone (MK-4), at a dose of 45 mg per day, a prescription dose far higher than typical supplements. The vitamin D3 arm used alfacalcidol (1alpha hydroxyvitamin D3), an active form of the vitamin.
Is calcium still important?
Calcium remains a dietary requirement for bone, but in this trial the calcium lactate group showed a significant decline in bone density. Calcium by itself was not enough for these women.
How long does it take to see results?
Bone density was measured at 1 year and again at 2 years, so this is a long-term investment rather than a quick change.
Conclusion
For postmenopausal women with osteoporosis, the combined use of vitamin D3 and vitamin K2 shows promise. In this 2-year randomized trial, the combination raised lumbar spine bone density more than calcium, more than D3 alone, and more than K2 alone, while calcium alone lost ground. Calcium still matters, but it should not be the only focus. Keep in mind that the trial was small, used prescription forms of both vitamins, and measured bone density rather than fractures.
